Organisation paid for research Program year 2023 Source: CMS Open Payments

Coastal Clinical Research

Neither a doctor nor a teaching hospital

Research payments

$516,463

68 payments

Through program year 2023, Coastal Clinical Research is reported as receiving $516,463 in research payments, across 68 payments.

By program year

5 rows
Year Kind Amount Payments
2023 Research $2,447 4
2022 Research $13,437 1
2021 Research $153 4
2020 Research $93,985 11
2019 Research $406,441 48

Breakdown

Who paid Research payments · program years 2019–2023
  1. Seqirus USA Inc $293,060 11 payments
  2. Takeda Pharmaceuticals U.S.A., Inc. $133,074 7 payments
  3. OPKO Pharmaceuticals, LLC $22,064 4 payments
  4. AMAG Pharmaceuticals, Inc. $20,154 4 payments
  5. Ucb SA $15,516 1 payment
  6. Pfizer Inc. $13,437 1 payment
  7. Bayer HealthCare Pharmaceuticals Inc. $11,078 6 payments
  8. Allergan Inc. $3,823 9 payments
  9. AbbVie, Inc. $2,447 4 payments
  10. Bausch Health US, LLC $1,300 1 payment
Studies the money was for Research payments · program years 2019–2023
  1. A Phase 3, Randomized, Observer-Blind, Multicenter, Noninferiority Study to Evaluate Safety and Immunogenicity of a Cell-Based Quadrivalent Subunit Influenza Virus Vaccine QIVc and a United States Licensed Quadrivalent Influenza Virus Vaccine QIV in Healthy Subjects 6 Months Through 47 Months $204,395 3 payments
  2. Immunogenicity and Safety of Tetravalent Dengue Vaccine TDV Administered With a Yellow Fever Vaccine in Adults $133,074 7 payments
  3. Safety and Immunogenicity Study of QIVc in Healthy Pediatric Subjects $88,666 8 payments
  4. Prasterone DHEA for the Treatment of Hypoactive Sexual Desire Disorder HSDD - Placebo-Controlled, Double Blind and Randomized Phase III Study of Intravaginal Prasterone $20,154 4 payments
  5. A Phase 3, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo- and Active-Controlled Study Followed By A Placebocontrolled Maintenance Period and Open-Label Follow-Up to Evaluate the Efficacy and Safety of Certolizumab Pegol in Subjects With Moderate to Severe Chronic Plaque Psoriasis $15,516 1 payment
  6. A Phase 3 Master Protocol to Evaluate Additional Doses of Bnt162b2 in Healthy Individuals Previously Vaccinated With Bnt162b2 $13,437 1 payment
  7. Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) $12,879 2 payments
  8. BAY1002670 Long term Safety vs SoC $11,078 6 payments
  9. Effects and Safety of OPK-88004 Doses in Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) $9,185 2 payments
  10. A Phase 2, Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Single Treatment, 2-Stage, Dose Finding Study Evaluating the Efficacy and Safety of Botox Intravesical Installation in Participants With Overactive Bladder and Urinary Incontinence. $2,718 7 payments
What the money was spent on Research payments · program years 2019–2023
  1. Other $25,196 3 payments

Only reported on some payments, and a payment can report more than one category, so these amounts overlap.

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.

Provenance

Source: CMS Open Payments · through program year 2023

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record